455 related articles for article (PubMed ID: 31622059)
1. [Antiviral effect of «Kagocel» substance in vitro on influenza viruses H1N1, H1N1pdm09 and H3N2.].
Fediakina IT; Konopleva MV; Proshina ES; Linnik EV; Nikitina NI
Vopr Virusol; 2019; 64(3):125-131. PubMed ID: 31622059
[TBL] [Abstract][Full Text] [Related]
2.
Lloren KKS; Kwon JJ; Choi WS; Jeong JH; Ahn SJ; Choi YK; Baek YH; Song MS
J Virol; 2019 Mar; 93(6):. PubMed ID: 30602610
[TBL] [Abstract][Full Text] [Related]
3. Impact of the Baloxavir-Resistant Polymerase Acid I38T Substitution on the Fitness of Contemporary Influenza A(H1N1)pdm09 and A(H3N2) Strains.
Checkmahomed L; M'hamdi Z; Carbonneau J; Venable MC; Baz M; Abed Y; Boivin G
J Infect Dis; 2020 Jan; 221(1):63-70. PubMed ID: 31419295
[TBL] [Abstract][Full Text] [Related]
4. Antiviral activity of novel oseltamivir derivatives against some influenza virus strains.
Kocik J; Kołodziej M; Joniec J; Kwiatek M; Bartoszcze M
Acta Biochim Pol; 2014; 61(3):509-13. PubMed ID: 25210935
[TBL] [Abstract][Full Text] [Related]
5. Antiviral activity of SA-2 against influenza A virus in vitro/vivo and its inhibition of RNA polymerase.
Yu J; Wang D; Jin J; Xu J; Li M; Wang H; Dou J; Zhou C
Antiviral Res; 2016 Mar; 127():68-78. PubMed ID: 26802558
[TBL] [Abstract][Full Text] [Related]
6. [Study of the antiviral activity of Russian anti-influenza agents in cell culture and animal models].
Leneva IA; Fediakina IT; Eropkin MIu; Gudova NV; Romanovskaia AA; Danilenko DM; Vinogradova SM; Lepeshkin AIu; Shestopalov AM
Vopr Virusol; 2010; 55(3):19-27. PubMed ID: 20608077
[TBL] [Abstract][Full Text] [Related]
7. Effect of aloin on viral neuraminidase and hemagglutinin-specific T cell immunity in acute influenza.
Huang CT; Hung CY; Hseih YC; Chang CS; Velu AB; He YC; Huang YL; Chen TA; Chen TC; Lin CY; Lin YC; Shih SR; Dutta A
Phytomedicine; 2019 Nov; 64():152904. PubMed ID: 31454654
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility of influenza viruses to hypothiocyanite and hypoiodite produced by lactoperoxidase in a cell-free system.
Patel U; Gingerich A; Widman L; Sarr D; Tripp RA; Rada B
PLoS One; 2018; 13(7):e0199167. PubMed ID: 30044776
[TBL] [Abstract][Full Text] [Related]
9. Identification and
Enkirch T; Sauber S; Anderson DE; Gan ES; Kenanov D; Maurer-Stroh S; von Messling V
Front Immunol; 2019; 10():1097. PubMed ID: 31244822
[TBL] [Abstract][Full Text] [Related]
10. Antiviral activity of a synthesized shikonin ester against influenza A (H1N1) virus and insights into its mechanism.
Zhang Y; Han H; Qiu H; Lin H; Yu L; Zhu W; Qi J; Yang R; Pang Y; Wang X; Lu G; Yang Y
Biomed Pharmacother; 2017 Sep; 93():636-645. PubMed ID: 28688289
[TBL] [Abstract][Full Text] [Related]
11. Antiviral activity of baicalin against influenza A (H1N1/H3N2) virus in cell culture and in mice and its inhibition of neuraminidase.
Ding Y; Dou J; Teng Z; Yu J; Wang T; Lu N; Wang H; Zhou C
Arch Virol; 2014 Dec; 159(12):3269-78. PubMed ID: 25078390
[TBL] [Abstract][Full Text] [Related]
12. [Evolution of pandemic influenza virus A(H1N1)pdm09 in 2009-2016: dynamics of receptor specificity of the first hemagglutinin subunit (HA1).].
Lvov DK; Bogdanova VS; Kirillov IM; Shchelkanov MY; Burtseva EI; Bovin NV; Fedyakina IT; Prilipov AG; Alhovsky SV; Samokhvalov EI; Proshina ES; Kirillova ES; Syroeshkin AV
Vopr Virusol; 2019; 64(2):63-72. PubMed ID: 31412172
[TBL] [Abstract][Full Text] [Related]
13. Identification and Characterization of Novel Compounds with Broad-Spectrum Antiviral Activity against Influenza A and B Viruses.
Park JG; Ávila-Pérez G; Nogales A; Blanco-Lobo P; de la Torre JC; Martínez-Sobrido L
J Virol; 2020 Mar; 94(7):. PubMed ID: 31941776
[TBL] [Abstract][Full Text] [Related]
14. Generation of a Reassortant Influenza A Subtype H3N2 Virus Expressing
Wang L; Cui Q; Zhao X; Li P; Wang Y; Rong L; Du R
Viruses; 2019 Jul; 11(7):. PubMed ID: 31330768
[TBL] [Abstract][Full Text] [Related]
15. Zanamivir-resistant influenza viruses with Q136K or Q136R neuraminidase residue mutations can arise during MDCK cell culture creating challenges for antiviral susceptibility monitoring.
Little K; Leang SK; Butler J; Baas C; Harrower B; Mosse J; Barr IG; Hurt AC
Euro Surveill; 2015; 20(45):. PubMed ID: 26608955
[TBL] [Abstract][Full Text] [Related]
16. Antiviral Activity of 3D, a Butene Lactone Derivative Against Influenza A Virus In Vitro and In Vivo.
Wang Z; Fang J; Luo J; Hou D; Tan Y; Gu Z; Ge Y; Mao L; Liu L; Liu H; Wei Z; Xu H
Viruses; 2021 Feb; 13(2):. PubMed ID: 33670217
[TBL] [Abstract][Full Text] [Related]
17. Cirsimaritin inhibits influenza A virus replication by downregulating the NF-κB signal transduction pathway.
Yan H; Wang H; Ma L; Ma X; Yin J; Wu S; Huang H; Li Y
Virol J; 2018 May; 15(1):88. PubMed ID: 29783993
[TBL] [Abstract][Full Text] [Related]
18. Eurasian Avian-like M1 Plays More Important Role than M2 in Pathogenicity of 2009 Pandemic H1N1 Influenza Virus in Mice.
Xie L; Xu G; Xin L; Wang Z; Wu R; Wu M; Cheng Y; Wang H; Yan Y; Ma J; Sun J
Viruses; 2021 Nov; 13(12):. PubMed ID: 34960604
[TBL] [Abstract][Full Text] [Related]
19. [Epidemiological features of prevalent influenza A viruses in children with influenza-like illness during the 2004-2017 season in Beijing].
Wang F; Qian Y; Deng J; Sun Y; Zhao LQ; Tian R; Zhu RN
Zhonghua Er Ke Za Zhi; 2018 Jun; 56(6):429-434. PubMed ID: 29886605
[No Abstract] [Full Text] [Related]
20. [In vitro and in vivo efficacy of Ingavirin against strains of pandemic influenza virus A(H1N1/09)v].
Shishkina LN; Nebol'sin VE; Kabanov AS; Skarnovich MO; Mazurkova NA; Sergeev AA; Serova OA; Stavskiĭ EA; Drozdov IG
Zh Mikrobiol Epidemiol Immunobiol; 2011; (2):93-6. PubMed ID: 21598625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]